ABSTRACT
This study retrospectively analyzed the feasible effectiveness of ultrasound-guided acupotomy (USGAP) for the treatment of frozen shoulder (FS). A total of 36 patients with FS were analyzed in this retrospective study. All 36 patients received extracorporeal shock-wave therapy (ESWT). In addition, 18 of them also underwent USGAP intervention and were assigned to a treatment group, while the other 18 patients did not receive such intervention and were assigned to a control group. The primary efficacy endpoint was pain intensity, as measured by the Numeric Rating Scale (NRS). The secondary efficacy endpoint was assessed by the score of shoulder pain and disability index (SPADI). Furthermore, the adverse events were also documented during the treatment period. All efficacy endpoints were measured after the treatment. After treatment, patients who received USGAP exerted better efficacy endpoints in pain relief, as measured by NRS scale (Pâ<â.01), and shoulder disorders, as evaluated by SPADI (Pâ<â.01), than subjects who did not receive USGAP. Additionally, no adverse events occurred in either group. The results of this study indicated that USGAP may be used for the treatment of FS effectively. More studies are still needed to warrant the present results.
Subject(s)
Acupuncture Therapy/methods , Bursitis/therapy , Extracorporeal Shockwave Therapy/methods , Therapy, Computer-Assisted/methods , Ultrasonography/methods , Bursitis/diagnosis , Female , Humans , Male , Middle Aged , Pilot Projects , Retrospective Studies , Treatment OutcomeABSTRACT
OBJECTIVE: To explore the Mechanism of Shanzha xiaozhi Capsule improving the functions of endonthelial cells in patients with dislipide mia. METHODS: To measurate the blood lipid and the levels of plasma Endothelin (ET) and nitrodi oxide (NO) in 30 patients with dislipide mia before and after taking the Shanzha xiaozhi Capsule, and there were 10 normal persons in control group, which were measured the blood lipid and the levels of ET and NO only one time. RESULTS: After treatment with Shanzha xiaozhi Capsule, the levels of triglyceride (TG), total cholesterol (TC), low density lipoprotein cholestero (LDL-C), ET were markedly reduced (P < 0.05), and the levels of NO were obviously elevated (P < 0.05). CONCLUSION: Shanzha xiaozhi Capsule can reduce blood lipid level and the plasma ET levels, increase the NO levels and the protection to the functions of endothelial cells which might be involved in the mechanisms of against atherosclerosis.
